Gilead Sciences, Inc. Profile Avatar - Palmy Investing

Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…
Drug Manufacturers - General
US, Foster City [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
9,698.00 11,592.00 17,303.00 21,239.00 22,496.00 34,664.00 51,839.00 56,977.00 70,283.00 63,675.00 61,627.00 68,407.00 67,952.00 63,171.00 62,125.00
Current
6,346.00 8,143.00 13,305.00 6,078.00 6,726.00 17,747.00 34,017.00 38,481.00 41,346.00 35,653.00 31,489.00 15,816.00 15,056.00 15,227.00 16,454.00
Non Current
3,352.00 3,448.00 3,998.00 15,161.00 15,770.00 16,917.00 17,822.00 18,496.00 28,937.00 28,022.00 30,138.00 52,591.00 52,896.00 47,944.00 45,671.00
Liabilities
3,193.00 5,470.00 10,435.00 11,688.00 10,752.00 18,845.00 32,726.00 37,614.00 49,782.00 42,141.00 38,977.00 50,186.00 46,888.00 41,962.00 39,376.00
Current
1,871.00 2,464.00 2,514.00 4,270.00 6,325.00 5,618.00 9,891.00 9,219.00 11,635.00 10,605.00 9,759.00 11,397.00 11,610.00 11,237.00 11,280.00
Non Current
1,321.00 3,005.00 7,920.00 7,418.00 4,426.00 13,227.00 22,835.00 28,395.00 38,147.00 31,536.00 29,218.00 38,789.00 35,278.00 30,725.00 28,096.00
Equity
6,643.00 6,379.00 6,995.00 9,791.00 12,119.00 16,212.00 19,692.00 19,839.00 20,560.00 21,681.00 22,775.00 18,240.00 21,059.00 21,178.00 22,665.00
Stockholders' Equity
6,505.00 6,121.00 6,867.00 9,550.00 11,744.00 15,819.00 19,113.00 19,363.00 20,501.00 21,534.00 22,650.00 18,221.00 21,064.00 21,209.00 22,749.00
Retained Earnings
1,995.00 1,183.00 1,776.00 3,704.00 6,105.00 12,732.00 18,001.00 18,154.00 19,012.00 19,024.00 19,388.00 14,381.00 16,324.00 15,687.00 16,304.00
Common Stock
- - - - - - - - 1.00 2.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Preferred Stock
138.00 258.00 128.00 241.00 375.00 393.00 579.00 476.00 59.00 147.00 - - - - - - - - 22,748.00
Profit
2,635.00 2,901.00 2,803.00 2,591.00 3,074.00 12,101.00 18,108.00 13,501.00 4,628.00 5,455.00 5,386.00 89.00 6,225.00 4,592.00 5,665.00
Dividends
- - - - - - - - - - - - -1,874.00 -2,455.00 -2,731.00 -2,971.00 -3,222.00 -3,449.00 -3,605.00 -3,709.00 -3,809.00
Minority Interest
138.00 258.00 128.00 241.00 375.00 393.00 579.00 476.00 59.00 147.00 125.00 19.00 -5.00 -31.00 -84.00
Other Stockholders' Equity
4,376.00 4,648.00 4,903.00 5,649.00 5,386.00 2,391.00 444.00 454.00 1,264.00 2,282.00 3,176.00 3,899.00 4,656.00 5,519.00 -16,332.00
Loss Other Compr. Income
-5.00 30.00 58.00 -45.00 -124.00 301.00 88.00 278.00 165.00 80.00 85.00 -60.00 83.00 2.00 28.00
End of GILD's Analysis
CIK: 882095 CUSIP: 375558103 ISIN: US3755581036 LEI: - UEI: -
Secondary Listings